172 related articles for article (PubMed ID: 16084101)
1. Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5.
Sunder-Plassmann N; Sarli V; Gartner M; Utz M; Seiler J; Huemmer S; Mayer TU; Surrey T; Giannis A
Bioorg Med Chem; 2005 Nov; 13(22):6094-111. PubMed ID: 16084101
[TBL] [Abstract][Full Text] [Related]
2. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and biological evaluation of tetrahydro-beta-carline derivatives].
Ruan XQ; You QD; Yang L; Wu WT
Yao Xue Xue Bao; 2008 Aug; 43(8):828-32. PubMed ID: 18956775
[TBL] [Abstract][Full Text] [Related]
4. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.
Takeuchi T; Oishi S; Watanabe T; Ohno H; Sawada J; Matsuno K; Asai A; Asada N; Kitaura K; Fujii N
J Med Chem; 2011 Jul; 54(13):4839-46. PubMed ID: 21599002
[TBL] [Abstract][Full Text] [Related]
7. A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5.
Nakazawa J; Yajima J; Usui T; Ueki M; Takatsuki A; Imoto M; Toyoshima YY; Osada H
Chem Biol; 2003 Feb; 10(2):131-7. PubMed ID: 12618185
[TBL] [Abstract][Full Text] [Related]
8. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities.
DeBonis S; Skoufias DA; Lebeau L; Lopez R; Robin G; Margolis RL; Wade RH; Kozielski F
Mol Cancer Ther; 2004 Sep; 3(9):1079-90. PubMed ID: 15367702
[TBL] [Abstract][Full Text] [Related]
9. The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
Barsanti PA; Wang W; Ni ZJ; Duhl D; Brammeier N; Martin E; Bussiere D; Walter AO
Bioorg Med Chem Lett; 2010 Jan; 20(1):157-60. PubMed ID: 19945875
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel EG5 inhibitors.
Sarli V; Huemmer S; Sunder-Plassmann N; Mayer TU; Giannis A
Chembiochem; 2005 Nov; 6(11):2005-13. PubMed ID: 16216042
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
12. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
[TBL] [Abstract][Full Text] [Related]
13. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
Nakai R; Iida S; Takahashi T; Tsujita T; Okamoto S; Takada C; Akasaka K; Ichikawa S; Ishida H; Kusaka H; Akinaga S; Murakata C; Honda S; Nitta M; Saya H; Yamashita Y
Cancer Res; 2009 May; 69(9):3901-9. PubMed ID: 19351824
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series.
Tarby CM; Kaltenbach RF; Huynh T; Pudzianowski A; Shen H; Ortega-Nanos M; Sheriff S; Newitt JA; McDonnell PA; Burford N; Fairchild CR; Vaccaro W; Chen Z; Borzilleri RM; Naglich J; Lombardo LJ; Gottardis M; Trainor GL; Roussell DL
Bioorg Med Chem Lett; 2006 Apr; 16(8):2095-100. PubMed ID: 16458511
[TBL] [Abstract][Full Text] [Related]
15. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.
Debonis S; Skoufias DA; Indorato RL; Liger F; Marquet B; Laggner C; Joseph B; Kozielski F
J Med Chem; 2008 Mar; 51(5):1115-25. PubMed ID: 18266314
[TBL] [Abstract][Full Text] [Related]
17. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
[TBL] [Abstract][Full Text] [Related]
18. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
Maliga Z; Kapoor TM; Mitchison TJ
Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
[TBL] [Abstract][Full Text] [Related]
19. The NIMA-family kinase Nek6 phosphorylates the kinesin Eg5 at a novel site necessary for mitotic spindle formation.
Rapley J; Nicolàs M; Groen A; Regué L; Bertran MT; Caelles C; Avruch J; Roig J
J Cell Sci; 2008 Dec; 121(Pt 23):3912-21. PubMed ID: 19001501
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
